Acquired factor VIII inhibitor and chronic lymphoid leukemia: A case report;INHIBITEUR ACQUIS DU FACTEUR VIII ET LEUCEMIE LYMPHOIDE CHRONIQUE: A PROPOS D'UN CAS

Revue de Medecine Interne

Volumn 17, Issue 2, 1996, Pages 150-153

  Ceballos, P ^a   Yeche, S ^a   Reynaud, D ^a   Mouliade, C ^a   Dubois, A ^a  

^a CMC Beau Soleil   (France)

Author keywords

acquired haemophilia; antibody; chronic lymphoid leukemia; coagulation factor

Indexed keywords

AUTOANTIBODY; BLOOD CLOTTING FACTOR 8 ANTIBODY;

AGED; ARTICLE; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; FEMALE; HEMOPHILIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT;

EID: 0029981383     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/0248-8663(96)82965-1     Document Type: Article

References (15)

1. Duran-Saurez JR. Acquired hemophilia. Lancet 1981;i:255
2. Green D, Lechner K. A survey of 215 non hemophilic patients with inhibitors to factor VIII. Thrombosis and Haemostasis 1987;58:1005-7
3. Goodrick MJ, Prentice AC, Copplestone JA et al. Acquired factor XI inhibitor in chronic lymphocytic leukaemia. J Clin Pathol 1992;45:352-3
4. Borche J, Lim A, Binet JL et al. Evidence that chronic lymphocytic leukaemia B lymphocytes are frequently commited to production of natural autoantibodies. Blood 1990;76:562-9
5. Parachini ML, Rocchini GM, Renoldi F et al. Acquired factor VIII inhibitor in a non hemophilic patient: successful treatment with plasma exchange associated with factor VIII concentrate and immunosuppressors. Haemostasis 1984;14:249-52
6. Wajima T, Hall G. Factor VIII inhibitor in insulin-dependent diabetes mellitus. Am J Hematol 1989;30:186-7
7. Negrier CN, Dechavanne M, Alfonsi F et al. Successful treatment of acquired factor VIII antibody by extracorporal immunoadsorption. Acta Hematol 1991;85:107-10
8. Sultan Y, Maisonneuve P, Kazatchine MD et al. Anti-idiotypic suppression of auto-antibodies to factor VIII by high dose of intravenous gammaglobulin. Lancet 1984;40:765-8
9. Singal V, Mammen EF. Concommitant occurence of disseminated intravascular coagulation and factor VIII inhibitor in a patient with prostatic cancer. Am J Hematol 1987;25:237-42
10. Muhn M, Grois N, Kier P et al. 1-deamino-8-D arginine vasopressin in the treatment of non hemophilic patients with acquired factor VIII inhibitor. Haemostasis 1990;20:15-20
11. Al Ismail SAD, Parry DH, Moisey CU et al. Factor VIII inhibitor and bronchogenic carcinoma. Thromb Haemostasis 1979;41:291-5
12. Godeau P, Blétry O. Piette JC et al. Anticoagulants circulants : les conditions cliniques du diagnostic. Rev Méd Interne 1985;6:523-41
13. Zimmermann R, Kommerell B, Harenbert J et al. Intravenous IgG for patients with spontaneous inhibitor to factor VIII. Lancet 1985;i:273-4
14. Heyman MR, Chakravarthy A, Edelman BB et al. Failure of high dose IV gammaglobulin in the treatment of spontaneously acquired factor VIII inhibitors. Am J Hematol 1988;28:191-4'
15. Green D, Kwaan HC. An acquired factor VIII inhibitor responsive to high dose gammaglobulin. Thromb Haemostasis 1987;58:1005-7